Explore News
-
Oral Drug Candidate Targets 3 Major Viral Threats in One Pill
A once-daily oral antiviral developed at Georgia State University effectively treats multiple dangerous orthoparamyxovir
-
Natural Compounds Cut COVID-19 Infection Risk by 80%
Galloylquinic acids from a Brazilian rainforest tree disrupt viral entry, replication, and inflammation—offering a rare
